28.10.2014 Views

Presentatie - vzw farmaka asbl

Presentatie - vzw farmaka asbl

Presentatie - vzw farmaka asbl

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Calcium-antagonisten<br />

25.Heidenreich. JAMA 1999;281:1927-36<br />

Design N/n Population Sd Interventions Outcomes Results<br />

MA<br />

(search<br />

date<br />

N=72 Angina<br />

pectoris<br />

35%<br />

Mean: 8w β-blocker vs caantagonists<br />

Angina episodes/w Mean difference=0.31 (95%CI –<br />

0.62 to 0,0) in favour of β-<br />

blockers<br />

1997)<br />

previous<br />

Nitroglycerin use/w No difference<br />

MI<br />

Time to 1 mm ST↓ No difference<br />

N=6 Mean: 5w β-blockers vs nitrates Same outcomes No difference<br />

N=12 Mean: 3w Nitrates vs ca-antagonists Same outcomes No difference<br />

www.<strong>farmaka</strong>.be<br />

Project<br />

Farmaka

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!